Detection of P53 Gene Mutations in 14 Tumor Cell Lines
MA Jia-lie,WEI Fang,LI Hui-ming,TIAN Yu-hua,CHEN Xia-fang,WANG Feng,HUANG Qian
DOI: https://doi.org/10.3872/j.issn.1007-385x.2008.02.014
2008-01-01
Abstract:Objective:To investigate P53 gene mutations in 14 tumor cell lines. Methods: Primers were designed according to the intron sequences locating between exons 5-8 of P53 gene for amplification of P53 gene exon 5-8 of the 14 tumor cell lines from 9 kinds of human carcinoma, namely, the lung cancer, gloma, hepatocarcinoma, gastric carcinoma, prostate carcinoma, mammary carcinoma, colonic carcinoma, choroidal melanoma, and retinoblastoma. The PCR products were subjected to electrophoresis; DNA sequencing was performed for the amplified product and the results were compared with wild-type P53 gene. Meanwhile, the P53 protein of 14 tumor cell lines was extracted for Western blotting analysis. Results: The products of exons 5-8 amplified by PCR were identical to that expected. The results of DNA sequencing showed that 8 of 14 tumor cell lines had P53 gene mutation in exons 5-8. Novel mutations were found in 4 tumor cell lines, including human lung cancer cell H1299, hepatocacinoma cell Hep3B and 7721, and choroidal melanoma cell OCM-1. The mutations mainly existed in the coding areas of the exons; most of them were missense mutations due to single base replacement; some others were silent mutations; and no mutations were found in the 2 normal cell lines. The results of Western blotting showed that only 6 of 8 mutant lines had P53 protein expression, which was not found in the non-mutant lines and the normal cells. Conclusion: We have identified 8 lines with mutant P53 genes among the 14 tumor cell lines, novel mutations are found in 4 tumor cell lines and none in the two normal cell lines.